• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018 Product Image

Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

  • Published: February 2013
  • Region: Global
  • 119 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Cardinal Health Inc.
  • Covidien Plc
  • GE Healthcare
  • IBA Group
  • Lantheus Medical Imaging
  • Nordion, Inc.
  • MORE

Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide.

Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Global Radiopharmaceuticals Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Radiopharmaceutical-Based Cancer Therapy
3.2.2 Growing Preference For Disease-Targeted Therapy
3.2.3 Increasing Awareness Of Accurate Diagnosis
3.2.4 Expanding Molecular Imaging Applications
3.3 Market Restraints
3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage
3.3.2 Worldwide Supply Shortages
3.3.3 Price Sensitivity And Competitive Alternatives
3.4 Market Opportunities
3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets
3.4.2 Radiopharmaceutical-Based Personalized Therapy

Chapter 4 Market Definition & Supply Chain Analysis
4.1 Market Definition
4.2 Radiopharmaceutical Production : A Global Perspective
4.3 Supply Chain Analysis

Chapter 5 Global Radiopharmaceutical Generators Market
5.1 Overview
5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
5.2 Mo-99/Tc-99m Generators
5.3 Sr-82/Rb-82 Generators
5.4 Ge-68/Ga-67,68 Generators
5.5 Sr-90/Y-90 Generators
5.6 W-188/Re-188 Generators

Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
6.1 Overview
6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
6.2 Hospitals and Medical Centers
6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018 (USD Million)
6.3 Outpatient Diagnostic Centers
6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)

Chapter 7 Global Radiopharmaceuticals Market, By Applications
7.1 Overview
7.2 Radiopharmaceuticals For Diagnosis
7.2.1 Overview
7.2.2 Radiopharmaceuticals For Diagnosis, By Technique
7.2.2.1 Single-Photon Emission Computed Tomography (SPECT)
7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
7.2.2.1.2 Technetium (Tc-99m)
7.2.2.1.3 Thallium (Tl-201)
7.2.2.1.4 Gallium (Ga-67)
7.2.2.1.5 Iodine (I-123)
7.2.2.1.6 Rhenium (Re-186)
7.2.2.1.7 Yttrium (Y-90)
7.2.2.1.8 Others
7.2.2.2 Positron Emission Tomography (PET)
7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
7.2.2.2.2 Fludeoxyglucose (18f-FDG)
7.2.2.2.3 Rubidium (Rb-82)
7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia)
7.2.3 Radiopharmaceuticals For Diagnosis, By Indications
7.2.3.1 Oncology
7.2.3.2 Cardiovascular
7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)
7.3 Radiopharmaceuticals For Therapy
7.3.1 Overview
7.3.2 Oncology (Systemic Therapy)
7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
7.3.2.2 Iodine (I-131)
7.3.2.3 Yttrium (Y-90)
7.3.2.4 Samarium (Sm-153)
7.3.2.5 Strontium (Sr-89)
7.3.2.6 Rhenium (186Re)
7.3.2.7 Lutetium-177 (Lu-177)
7.3.2.8 Erbium-169 (169Er)
7.3.2.9 Others
7.3.3 Other Applications In Therapy (Cardiology, Neurology)
7.4 Theranostics

Chapter 8 Global Radiopharmaceuticals Market, By Geography
8.1 Overview
8.2 North America
8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.3 Europe
8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.4 Asia-Pacific (Apac)
8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.5 Rest of the World (RoW)
8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

Chapter 9 Market Share Analysis By Key Players
9.1 Radiopharmaceuticals Market
9.2 Generators Market

Chapter 10 Recommendations
10.1 Identification and Elimination Of Barriers
10.2 Development of Total Solutions
10.3 Investing in Emerging Markets
10.4 Entering Monopoly Markets

Chapter 11 Company Profiles
11.1 Cardinal Health Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Business Strategies
11.1.3.1 Mergers and Acquisitions
11.1.3.2 External Funding
11.1.3.3 Incorporation of Advanced Technologies to Support Business Development
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Covidien Plc
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Financial Overview
11.2.4 Strategic Overview
11.2.4.1 Mergers and Acquisitions
11.2.4.2 Approvals
11.2.5 Recent Developments
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Financial Overview
11.3.4 Strategic Overview
11.3.4.1 Mergers and Acquisitions
11.3.5 Recent Developments
11.4 IBA Group
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Product Portfolio
11.5 Lantheus Medical Imaging
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Business Strategies
11.5.3.1 Rigorous Research and Development Initiatives
11.5.3.2 Selling Generic Products to Maintain Market Share
11.5.4 Product Portfolio
11.5.4.1 Recent Developments
11.6 Monrol Nuclear Products, Inc.
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Strategic Overview
11.6.3.1 Mergers and Acquisitions
11.6.3.2 Collaborations
11.6.4 Recent Developments
11.7 Nordion, Inc.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Financial Overview
11.7.4 Strategic Overview
11.7.4.1 Contracts and Agreements
11.7.4.2 Divestiture
11.7.5 Recent Developments
11.7.5.1 New Product Launch
11.8 NTP Radioisotopes (Pty) Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Business Strategies
11.8.3.1 Media Campaigns as a Brand Management Tool
11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances
11.8.4 Product Portfolio
11.8.5 Recent Developments
11.9 Polatom
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Business Strategies
11.9.3.1 Maintaining an Extensive Network of Distributors
11.9.4 Product Portfolio
11.9.5 Recent Developments
11.10 Positron Corporation
11.10.1 Company Overview
11.10.2 Product Portfolio
11.10.3 Financial Overview
11.10.4 Strategic Overview
11.10.4.1 Contracts and Agreements
11.10.4.2 Collaborations
11.10.5 Recent Developments
11.10.5.1 Grants and Licenses
11.10.5.2 Incentives
11.11 Siemens Healthcare
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Business Strategies
11.11.3.1 Investing In Emerging Economies
11.11.3.2 Rigorous Research and Development Initiatives
11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013)
11.11.3.4 Maintaining An Extensive Suppliers Network
11.11.4 Product Portfolio
11.11.5 Recent Developments

LIST OF FIGURES

Fig. 1 Radiopharmaceuticals Market Segmentation
Fig. 2 Global Radiopharmaceuticals Market Snapshot
Fig. 3 Global Radiopharmaceuticals Market, By Application, 2011 (USD Million)
Fig. 4 Radiopharmaceuticals Market Attractiveness Analysis, By Geography (2011)
Fig. 5 Global Demand For Tc-99m (2009)
Fig. 6 Supply Chain - Global Radiopharmaceuticals Market
Fig. 7 Global Mo-99/Tc-99m Generators Market, 2010 – 2018 (USD Million)
Fig. 8 Global Sr-82/Rb-82 Generators Market, 2010 – 2018 (USD Million)
Fig. 9 Global Ge-68/Ga-67,68 Generators Market, 2015 – 2018 (USD Million)
Fig. 10 Global Sr-90/Y-90 Generators Market, 2016 – 2018 (USD Million)
Fig. 11 Global W-188/Re-188 Generators Market, 2016 – 2018 (USD Million)
Fig. 12 Global Radiopharmaceuticals Market By End User Groups : Hospitals And Medical Centres, 2010 – 2018 (USD Million)
Fig. 13 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)
Fig. 14 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
Fig. 15 Global Tc-99m Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 16 Global Tl-201 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 17 Global Ga-67 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 18 Global Iodine (I-123) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 19 Global Rhenium (Re-186) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 20 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 21 Global Others (In SPECT) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 22 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
Fig. 23 Global Fludeoxyglucose (18f-FDG) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 24 Global Rubidium (Rb-82) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 25 Global Others (In PET) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 26 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
Fig. 27 Global Iodine (I-131) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 28 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 29 Global Samarium (Sm-153) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 30 Global Strontium (Sr-89) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 31 Global Rhenium (186Re) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 32 Global Lutetium (Lu-177) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 33 Global Erbium (169Er) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 34 Global Other Applications In Therapy Radioisotopes Market, 2010 – 2018 (USD Million)
Fig. 35 Radiopharmaceuticals: Market Share Analysis Of Key Players, 2011 (%)
Fig. 36 Annual Revenues: Cardinal Health Inc., 2010 – 2012 (USD Million)
Fig. 37 Annual Revenues: Covidien Plc, 2009 – 2011 (USD Million)
Fig. 38 Annual Revenues: Ge Healthcare, 2009 – 2011 (USD Million)
Fig. 39 Annual Revenues: IBA Group, 2009 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)
Fig. 40 Annual Revenues: Lantheus Medical Imaging, 2010 – 2011 (USD Million)
Fig. 41 Annual Revenues: Nordion, Inc., 2009 – 2011 (USD Million)
Fig. 42 Annual Revenues: Positron Corporation, 2009 – 2011 (USD Million)
Fig. 43 Annual Revenues: Siemens Healthcare, 2010 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)

LIST OF TABLES

Table 1 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 2 Global Radiopharmaceuticals Generators Market By Segments, 2010 – 2018 (USD Million)
Table 3 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
Table 4 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
Table 5 Global Radiopharmaceuticals Market, By Applications, 2010-2018 (USD Million)
Table 6 Global Radiopharmaceuticals Market, By Region, 2010 – 2018 (USD Million)
Table 7 Global Radiopharmaceuticals Market, By Diagnosis, 2010-2018 (USD Million)
Table 8 Global SPECT Market, By Radioisotopes, 2010-2018 (USD Million)
Table 9 Gallium Compounds: Ongoing Studies
Table 10 Global PET Market, By Radioisotopes, 2010-2018 (USD Million)
Table 11 Global Radiopharmaceuticals Therapy Market, By Indications, 2010-2018 (USD Million)
Table 12 Global Systemic Therapy Market, By Radioisotopes, 2010-2018 (USD Million)
Table 13 Radionuclides and Their Applications (Diagnostics/Therapies)
Table 14 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 15 North America Radiopharmaceuticals Market - Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 16 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 17 Europe Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 18 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 19 Asia-Pacific Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 20 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 21 RoW Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 22 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

- Cardinal Health Inc.
- Covidien Plc
- GE Healthcare
- IBA Group
- Lantheus Medical Imaging
- Monrol Nuclear Products, Inc.
- Nordion, Inc.
- NTP Radioisotopes (Pty) Ltd
- Polatom
- Positron Corporation
- Siemens Healthcare

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos